Nancy Devlin : Citation Profile

Are you Nancy Devlin?

University of Melbourne (47% share)
University of Sheffield (47% share)
Office of Health Economics (6% share)

12

H index

14

i10 index

513

Citations

RESEARCH PRODUCTION:

51

Articles

51

Papers

4

Books

RESEARCH ACTIVITY:

   26 years (1994 - 2020). See details.
   Cites by year: 19
   Journals where Nancy Devlin has often published
   Relations with other researchers
   Recent citing documents: 61.    Total self citations: 64 (11.09 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde347
   Updated: 2020-08-09    RAS profile: 2020-05-05    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Shah, Koonal (19)

Feng, Yan (13)

Parkin, David (8)

Hampson, Grace (6)

Cole, Amanda (6)

Cubi-Molla, Patricia (4)

Rice, Nigel (4)

Zamora, Bernarda (3)

Mott, David (3)

O'Neill, Phill (2)

Karlsberg Schaffer, Sarah (2)

Shah, Kalim (2)

Karlsberg, Sarah (2)

Garau, Martina (2)

Brazier, John (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin.

Is cited by:

Brouwer, Werner (16)

Brazier, John (12)

Attema, Arthur (12)

Tsuchiya, Aki (12)

Siciliani, Luigi (10)

Towse, Adrian (10)

Shah, Koonal (10)

Blankart, Katharina (10)

Hernandez Alava, Monica (8)

Street, Andrew (7)

Claxton, Karl (7)

Cites to:

Shah, Koonal (52)

Parkin, David (42)

Feng, Yan (35)

Tsuchiya, Aki (34)

Brazier, John (20)

Rice, Nigel (15)

Roberts, Jennifer (12)

Appleby, John (8)

Claxton, Karl (7)

Street, Andrew (7)

Brouwer, Werner (6)

Main data

Where Nancy Devlin has published?

Journals with more than one article published# docs
Health Economics15
The European Journal of Health Economics10
PharmacoEconomics9
Health Policy4
Social Science & Medicine4
Applied Health Economics and Health Policy2

Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics26
Working Papers / Department of Economics, City University London11
Consulting Reports / Office of Health Economics6
Working Papers / Centre for Health Economics, University of York5

Recent works citing Nancy Devlin (2020 and 2019)

YearTitle of citing document
2017Scoping review on social care economic evaluation methods. (2017). Sculpher, Mark ; Faria, Rita ; van den Berg, Bernard ; Edwards, Mary ; Baragula, Erin ; Isojarvi, Jaana ; Glanville, Julie ; Nolan, Kay ; Oaneill, Peter ; Weatherly, Helen . In: Working Papers. RePEc:chy:respap:150cherp.

Full description at Econpapers || Download paper

2020A systematic review of child-focused outcomes and assessments of arts therapies delivered in primary mainstream schools. (2020). Powell, Joanne ; Karkou, Vicky ; Aithal, Supritha ; Moula, Zoe. In: Children and Youth Services Review. RePEc:eee:cysrev:v:112:y:2020:i:c:s0190740919313040.

Full description at Econpapers || Download paper

2017Good, better, best? A comprehensive comparison of healthcare providers’ performance: An application to physiotherapy practices in primary care. (2017). Steenhuis, Sander ; Portrait, France ; Koolman, Xander ; Groeneweg, Niels. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1225-1232.

Full description at Econpapers || Download paper

2017New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations. (2017). Shiroiwa, Takeru ; Takura, Tomoyuki ; Ikeda, Shunya ; Fukuda, Takashi. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:8:p:836-841.

Full description at Econpapers || Download paper

2018An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?. (2018). Shafrin, Jason ; Jansen, Jeroen ; Penrod, John R ; Hertel, Nadine ; Lees, Michael ; Villeneuve, Julie ; Brauer, Michelle ; Skornicki, Michelle. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:607-613.

Full description at Econpapers || Download paper

2019Shedding light on the HTA consultancy market: Insights from Poland. (2019). Botz, Lajos ; Kalo, Zoltan ; King, Lawrence ; Loblova, Olga ; Ozieraski, Piotr ; Csanadi, Marcell. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:12:p:1237-1243.

Full description at Econpapers || Download paper

2019What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. (2019). Cairns, John ; Maynou, Laia. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:130-139.

Full description at Econpapers || Download paper

2019Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?. (2019). Trapero-Bertran, M ; Aranda-Reneo, I ; Ramos-Goi, J M ; Lopez-Bastida, J ; Martin, Rodriguez B ; Kanavos, P. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:152-158.

Full description at Econpapers || Download paper

2019Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states. (2019). Rupel, Valentina Prevolnik ; Fernandez, Natacha Bolanos ; Murovec, Nika ; Ogorevc, Marko. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:166-172.

Full description at Econpapers || Download paper

2019Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy. (2019). Nuti, Sabina ; Berta, Paolo ; Seghieri, Chiara. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:5:p:449-456.

Full description at Econpapers || Download paper

2020Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble. (2020). Brouwer, Werner ; Attema, Arthur ; Lipman, Stefan A. In: Journal of Health Economics. RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619302279.

Full description at Econpapers || Download paper

2018Using path analysis to investigate the relationships between standardized instruments that measure health-related quality of life, capability wellbeing and subjective wellbeing: An application in the . (2018). Engel, Lidia ; David, ; Noonan, Vanessa K ; Bryan, Stirling. In: Social Science & Medicine. RePEc:eee:socmed:v:213:y:2018:i:c:p:154-164.

Full description at Econpapers || Download paper

2019How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations. (2019). Hauck, Katharina ; Culyer, Anthony ; Vassall, A ; Thomas, R ; Over, M ; Meacock, R ; Levin, C ; Chi, Y-Ling ; Chalkidou, K ; Smith, P C ; Morton, A ; Verguet, S. In: Social Science & Medicine. RePEc:eee:socmed:v:220:y:2019:i:c:p:141-149.

Full description at Econpapers || Download paper

2019A comparison of professional and private time preferences of General Practitioners. (2019). Phimister, Euan ; van der Pol, Marjon ; Irvine, Alastair. In: Social Science & Medicine. RePEc:eee:socmed:v:222:y:2019:i:c:p:256-264.

Full description at Econpapers || Download paper

2019Mind the (inter-rater) gap. An investigation of self-reported versus proxy-reported assessments in the derivation of childhood utility values for economic evaluation: A systematic review. (2019). Ratcliffe, Julie ; Lancsar, Emily ; Petrou, Stavros ; Kwon, Joseph ; Khadka, Jyoti. In: Social Science & Medicine. RePEc:eee:socmed:v:240:y:2019:i:c:s0277953619305374.

Full description at Econpapers || Download paper

2019Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study. (2019). Carter, Stacy M ; Donaldson, Cam ; Parkin, David ; Seymour, Janelle ; Lancsar, Emily ; Pickles, Kristen. In: Social Science & Medicine. RePEc:eee:socmed:v:240:y:2019:i:c:s0277953619305544.

Full description at Econpapers || Download paper

2020Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework. (2020). Molina-Lopez, T ; Montibeller, G ; Linch, M ; Angelis, A ; Kanavos, P ; Espin, J ; Arickx, F ; Orzel, K ; Zawada, A. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619305908.

Full description at Econpapers || Download paper

2020Can healthcare choice be predicted using stated preference data?. (2020). Swait, Joffre ; Donkers, Bas ; Bliemer, Michiel ; de Bekker-Grob, E W ; Veldwijk, J ; Bliemer, M. C. J., . In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307312.

Full description at Econpapers || Download paper

2020Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

Full description at Econpapers || Download paper

2018Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?. (2018). Debonneuil, Edouard ; Planchet, Frederic ; Eyraud-Loisel, Anne. In: Risks. RePEc:gam:jrisks:v:6:y:2018:i:3:p:67-:d:155814.

Full description at Econpapers || Download paper

2020Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee. (2020). Peter, Luka ; Mareova, Petra ; Kua, Kamil ; Klimova, Blanka ; Mohelska, Hana ; Augustnek, Martin ; Penhaker, Marek ; Ren, Luka ; Honegr, Jan. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:5:p:1755-:d:325509.

Full description at Econpapers || Download paper

2020Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary. (2020). Szabo-Morvai, Agnes ; Biro, Aniko. In: IEHAS Discussion Papers. RePEc:has:discpr:2018.

Full description at Econpapers || Download paper

2017Rationing in health care provision: a welfare approach. (2017). LEVAGGI, ROSELLA. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:17:y:2017:i:2:d:10.1007_s10754-016-9209-1.

Full description at Econpapers || Download paper

2020Performance Management Strategy: Waiting Time in the English National Health Services. (2020). Cookson, Graham ; Elkomy, Shimaa. In: Public Organization Review. RePEc:kap:porgrv:v:20:y:2020:i:1:d:10.1007_s11115-018-0425-7.

Full description at Econpapers || Download paper

2020Elicitation and modelling of imprecise utility of health states. (2020). Golicki, Dominik ; Jakubczyk, Micha. In: Theory and Decision. RePEc:kap:theord:v:88:y:2020:i:1:d:10.1007_s11238-019-09707-6.

Full description at Econpapers || Download paper

2019The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment. (2019). Brassel, Simon ; Towse, A ; Rozanova, O. In: Research Papers. RePEc:ohe:respap:002154.

Full description at Econpapers || Download paper

2019.

Full description at Econpapers || Download paper

2020Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: A cross-sectional study. (2020). Joseph, Royes ; Alshayban, Dhfer. In: PLOS ONE. RePEc:plo:pone00:0227573.

Full description at Econpapers || Download paper

2020A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852.

Full description at Econpapers || Download paper

2017Challenges in the Measurement of Public Sector Productivity in OECD 180 Countries. (2017). Edwin, Zsuzsanna Lonti ; Schultz, Rebecca . In: International Productivity Monitor. RePEc:sls:ipmsls:v:32:y:2017:10.

Full description at Econpapers || Download paper

2017Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review. (2017). Schiller-Fruhwirth, Irmgard C ; Siebert, Uwe ; Arvandi, Marjan ; Jahn, Beate . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-017-0312-3.

Full description at Econpapers || Download paper

2017Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage. (2017). Paolucci, Francesco ; Fiorentini, Gianluca ; Fouda, Ayman ; Redekop, Ken. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0349-3.

Full description at Econpapers || Download paper

2018Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions. (2018). Ho, Carlos King ; Bernard, ; Wu, Olivia. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:1:d:10.1007_s40258-017-0339-5.

Full description at Econpapers || Download paper

2019Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance. (2019). Crispi, Francisca ; Mossialos, Elias ; Osipenko, Leeza ; Barkauskaite, Eva ; Naci, Huseyin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:17:y:2019:i:2:d:10.1007_s40258-018-0438-y.

Full description at Econpapers || Download paper

2018Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Angelis, Aris ; Kanavos, Panos ; Lange, Ansgar . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

Full description at Econpapers || Download paper

2018Investigating the relationship between costs and outcomes for English mental health providers: a bi-variate multi-level regression analysis. (2018). Moran, Valerie ; Jacobs, Rowena. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:5:d:10.1007_s10198-017-0915-5.

Full description at Econpapers || Download paper

2019Are cost differences between specialist and general hospitals compensated by the prospective payment system?. (2019). Street, Andrew ; Siciliani, Luigi ; Longo, Francesco. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-017-0935-1.

Full description at Econpapers || Download paper

2019Future unrelated medical costs need to be considered in cost effectiveness analysis. (2019). Brouwer, Werner ; Meltzer, David ; Morton, Alec ; Baal, Pieter. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-018-0976-0.

Full description at Econpapers || Download paper

2019Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary. (2019). Baji, Petra ; Gulacsi, Laszlo ; Major, Klara ; Zrubka, Zsombor ; Brodszky, Valentin ; Beretzky, Zsuzsanna ; Rencz, Fanni ; Hajdu, Otto ; Pentek, Marta. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01059-w.

Full description at Econpapers || Download paper

2019Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS. (2019). Hermann, Zoltan ; Pentek, Marta ; Rencz, Fanni ; Brodszky, Valentin ; Gulacsi, Laszlo ; Zrubka, Zsombor. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01060-3.

Full description at Econpapers || Download paper

2019Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. (2019). Meregaglia, Michela ; Tarricone, Rosanna ; Cairns, John ; Borsoi, Ludovica. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-017-0930-6.

Full description at Econpapers || Download paper

2020Economic evaluation of meningococcal vaccines: considerations for the future. (2020). Shah, Koonal ; Lorgelly, Paula ; York, Laura ; Landa, Paolo ; Wright, Claire ; Bloom, David E ; Glennie, Linda ; Postma, Maarten J ; Smith, Vinny ; Levy, Pierre ; HERNaNDEZ-VILLAFUERTE, KARLA ; Al-Janabi, Hareth ; Christensen, Hannah ; Towse, Adrian K ; Diez-Domingo, Javier ; Salisbury, David M ; Farkouh, Raymond ; Damm, Oliver . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:2:d:10.1007_s10198-019-01129-z.

Full description at Econpapers || Download 2020

Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0.

Full description at Econpapers || Download paper

2019Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree. (2019). Herpers, M ; Ruof, J ; Worm, F ; Dintsios, C M. In: Health Economics Review. RePEc:spr:hecrev:v:9:y:2019:i:1:d:10.1186_s13561-019-0254-6.

Full description at Econpapers || Download paper

2019A novel approach to increase physical activity in older adults in the community using citizen science: a mixed-methods study. (2019). Frei, Anja ; Puhan, Milo A ; Knopfli, Nevil ; Stone, Emily ; Radtke, Thomas ; Lana, Kaba Dalla. In: International Journal of Public Health. RePEc:spr:ijphth:v:64:y:2019:i:5:d:10.1007_s00038-019-01230-3.

Full description at Econpapers || Download paper

2019EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery. (2019). Luo, Nan ; Janssen, Mathieu F ; Tan, Rachel Lee-Yin ; Wei, Yvonne Chung-Hsi ; Wong, Cheewai ; Teo, Kelvin ; Ang, Marcus ; Gandhi, Mihir. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:12:y:2019:i:4:d:10.1007_s40271-018-00354-7.

Full description at Econpapers || Download paper

2017Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss. (2017). , Ulrikke ; Norheim, Ole F ; Ottersen, Trygve ; Johansson, Kjell A. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0524-2.

Full description at Econpapers || Download paper

2018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

2018Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review. (2018). Lancsar, Emily ; Gu, Yuanyuan ; Zavarsek, Silva ; Ghijben, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0586-1.

Full description at Econpapers || Download paper

2018The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian On. (2018). Skedgel, Chris ; Hu, Min ; Wranik, Dominika. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-018-0610-0.

Full description at Econpapers || Download paper

2019The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. (2019). pudney, stephen ; Wailoo, Allan ; Hernandez-Alava, Monica ; Pennington, Becky. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0701-y.

Full description at Econpapers || Download paper

2019One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. (2019). Mulhern, Brendan ; Viney, Rosalie ; Street, Deborah J ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0714-6.

Full description at Econpapers || Download paper

2019Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature. (2019). Wittenberg, Eve ; Prosser, Lisa A ; James, Lyndon P. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7.

Full description at Econpapers || Download paper

2017Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR). (2017). Masucci, Lisa ; Hoch, Jeffrey S ; Sabharwal, Mona ; Beca, Jaclyn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0018-3.

Full description at Econpapers || Download paper

2017Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Round, Jeff ; Hawton, Annie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2.

Full description at Econpapers || Download paper

2019Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations. (2019). Pickard, Rob ; Vale, Luke ; Breckons, Matthew ; Mott, David ; Hill, Sarah ; Shen, Jing. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:1:d:10.1007_s41669-018-0084-1.

Full description at Econpapers || Download paper

2019Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma. (2019). Pescott, Chris ; Hatswell, Anthony ; Stapelkamp, Ceilidh ; Lilley, Cameron ; Amin, Amerah ; Willis, Anna ; Nathan, Paul ; Bullement, Ash ; Bharmal, Murtuza. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-018-0115-y.

Full description at Econpapers || Download paper

2020Tolerance intervals for autoregressive models, with an application to hospital waiting lists. (2020). Cheng, Kedai ; Young, Derek S. In: Applied Stochastic Models in Business and Industry. RePEc:wly:apsmbi:v:36:y:2020:i:2:p:268-282.

Full description at Econpapers || Download paper

2019Development of clinical value unit method for calculating patient costs. (2019). Pyke, Chris ; Cyganski, Piotr ; Cyganska, Malgorzata. In: Health Economics. RePEc:wly:hlthec:v:28:y:2019:i:8:p:971-983.

Full description at Econpapers || Download paper

Works by Nancy Devlin:

YearTitleTypeCited
1995Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform.
[Full Text][Citation analysis]		article0
1994The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health.
[Citation analysis]		article0
2000The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers.
[Full Text][Citation analysis]		paper1
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]		paper14
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK‐ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14		article
2012Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers.
[Full Text][Citation analysis]		paper1
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper30
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]		paper22
2013The Influence of Cost-effectiveness and Other Factors on NICE Decisions.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22		paper
2015The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22		article
20031 In: Working Papers.
[Full Text][Citation analysis]		paper12
20041.(2004) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20041.(2004) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20061.(2006) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20081.(2008) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20081.(2008) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20091.(2009) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
20091.(2009) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 12		paper
2005Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models In: Working Papers.
[Full Text][Citation analysis]		paper0
2009A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Working Papers.
[Full Text][Citation analysis]		paper1
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients In: Working Papers.
[Full Text][Citation analysis]		paper2
2015Local health care expenditure plans and their opportunity costs In: Health Policy.
[Full Text][Citation analysis]		article2
1996The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy.
[Full Text][Citation analysis]		article5
2006Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy.
[Full Text][Citation analysis]		article7
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]		article15
2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine.
[Full Text][Citation analysis]		article0
1999The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine.
[Full Text][Citation analysis]		article2
2005Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine.
[Full Text][Citation analysis]		article9
2009A note on the nature of utility in time and health and implications for cost utility analysis In: Social Science & Medicine.
[Full Text][Citation analysis]		article3
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]		article32
2000Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series.
[Full Text][Citation analysis]		paper0
2016New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings.
[Full Text][Citation analysis]		paper0
2012Time Trends in NICE HTA Decisions In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response In: Consulting Reports.
[Full Text][Citation analysis]		paper6
2015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports.
[Full Text][Citation analysis]		paper3
2016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making In: Consulting Reports.
[Full Text][Citation analysis]		paper1
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2011Incorporating Multiple Criteria in HTA: Methods and Processes In: Monographs.
[Full Text][Citation analysis]		book20
2010Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monographs.
[Full Text][Citation analysis]		book6
2002Cost-Effectiveness Thresholds: Economic and ethical issues In: Monographs.
[Full Text][Citation analysis]		book11
2004How Much Should We Spend on the NHS? In: Monographs.
[Full Text][Citation analysis]		book1
2013Searching for Cost-effectiveness Thresholds in NHS Scotland In: Research Papers.
[Full Text][Citation analysis]		paper0
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinsons Disease Patients In: Research Papers.
[Full Text][Citation analysis]		paper0
2012Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers.
[Full Text][Citation analysis]		paper4
2012Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Papers.
[Full Text][Citation analysis]		paper0
2011Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches In: Research Papers.
[Full Text][Citation analysis]		paper1
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers.
[Full Text][Citation analysis]		paper0
2010A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers.
[Full Text][Citation analysis]		paper10
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 10		article
2014Opportunity Costs of Implementing NICE Decisions in NHS Wales In: Research Papers.
[Full Text][Citation analysis]		paper1
2014What Determines the Shape of an EQ-5D Index Distribution? In: Research Papers.
[Full Text][Citation analysis]		paper1
2015An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers.
[Full Text][Citation analysis]		paper35
2018Valuing health‐related quality of life: An EQ‐5D‐5L value set for England.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 35		article
2016New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers.
[Full Text][Citation analysis]		paper8
2018New methods for modelling EQ‐5D‐5L value sets: An application to English data.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 8		article
2016A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers.
[Full Text][Citation analysis]		paper2
2016The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers.
[Full Text][Citation analysis]		paper0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0		article
2016An Analysis of NICE Technology Appraisal Decisions Recommended in Line with Clinical Practice In: Research Papers.
[Full Text][Citation analysis]		paper0
2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers.
[Full Text][Citation analysis]		paper0
2017Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers.
[Full Text][Citation analysis]		paper2
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 2		article
2017Age and Utilities: Issues for HTA In: Research Papers.
[Full Text][Citation analysis]		paper0
2017A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers.
[Full Text][Citation analysis]		paper0
2018New Methods for Analysing the Distribution of EQ-5D Observations In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers.
[Full Text][Citation analysis]		paper0
2020Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead In: Research Papers.
[Full Text][Citation analysis]		paper0
2013The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment In: PLOS ONE.
[Full Text][Citation analysis]		article5
2012Time to tweak the TTO. But how? In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2017EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article6
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article3
2013The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article7
2013The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2017Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2019Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2005A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2017Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2013Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics.
[Full Text][Citation analysis]		article9
2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
20183L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2018Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2001Health care spending and economic output: Granger causality In: Applied Economics Letters.
[Full Text][Citation analysis]		article39
2002The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics.
[Full Text][Citation analysis]		article0
2003Logical inconsistencies in survey respondents health state valuations ‐ a methodological challenge for estimating social tariffs In: Health Economics.
[Full Text][Citation analysis]		article8
2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]		article92
2004Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1‐85775‐575‐8 In: Health Economics.
[Full Text][Citation analysis]		article0
2006A theoretical framework for TTO valuations of health In: Health Economics.
[Full Text][Citation analysis]		article4
2006Is there a case for using visual analogue scale valuations in cost‐utility analysis? In: Health Economics.
[Full Text][Citation analysis]		article23
2007‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics.
[Full Text][Citation analysis]		article0
2010Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D data In: Health Economics.
[Full Text][Citation analysis]		article7
2011A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Health Economics.
[Full Text][Citation analysis]		article22
2015INTER‐PROVIDER COMPARISON OF PATIENT‐REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]		article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated July, 2 2020. Contact: CitEc Team